PMID Title Journal Publication Year Author View in RVdb
37846599 Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma. Allergy 2023 Sverrild A;Cerps S;Nieto-Fontarigo JJ;Ramu S;Hvidtfeldt M;Menzel M;Kearley J;Griffiths JM;Parnes JR;Porsbjerg C;Uller L View More